EXPERIENCE REPLACEMENT DRUGS OF VALPROIC ACID IN CHILDREN OUTPATIENT CLINIC

QR Code

EXPERIENCE REPLACEMENT DRUGS OF VALPROIC ACID IN CHILDREN OUTPATIENT CLINIC

Abstract: the article presents the clinical observation of outpatients with a diagnosis of epilepsy in the children’s neurological department Morozovsky Children Hospital translation from the original on generic drug valproic acid. Such changes in anticonvulsant therapy in patients quarter led to a...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. O. Schederkina, N. N. Zavadenko, I. E. Koltunov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2016-05-01
Series:	Эпилепсия и пароксизмальные состояния
Subjects:	epilepsy valproic acid generics change anticonvulsant therapy
Online Access:	https://www.epilepsia.su/jour/article/view/136
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF VALPROIC ACID DERIVATIVES
by: O. L. Badalyan, et al.
Published: (2016-05-01)

THE BASIC REGULATOR OF THE CIRCADIAN SYSTEM IN EPILEPSY
by: G. N. Avakyan, et al.
Published: (2016-05-01)

USE OF VALPROIC ACID IN WOMEN WITH EPILEPSY DURING PREGNANCY
by: A. V. Yakunina, et al.
Published: (2017-11-01)

DISSOLUTION PROFILE STUDY FOR EXTENDED RELEASE VALPROIC ACID DOSAGE FORM (DEPAKINE® CHRONO)
by: A. A. Lvova, et al.
Published: (2019-01-01)

DISSOLUTION PROFILE STUDY OF EXTENDED RELEASE VALPROIC ACID DRUG PRODUCTS FROM DIFFERENT MANUFACTURERS
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01)

TREATMENT OF EPILEPSY WITH PROLONGED VALPROIC ACID FORMULATIONS IN OUT-PATIENT SETTINGS
by: G. N. Avakyan, et al.
Published: (2016-08-01)

The Effect of Anti-Inflammatory Dimethylmalonic Acid on the Neurobehavioral Phenotype of a Neonatal ASD Model Induced by Antiepileptic Valproic Acid
by: Xiuwen Zhou, et al.
Published: (2025-07-01)

Pharmacokinetic Interactions of Phenosanic Acid with Valproic Acid and Carbamazepine in Dogs
by: M. V. Karlina, et al.
Published: (2022-12-01)

THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIEPILEPTIC DRUGS
by: A. V. Yakunina, et al.
Published: (2016-12-01)

4-BENZOYLPYRIDINE OXIME DERIVATIVE (GIZH-298) VERSUS VALPROIC ACID: THE ANTICONVULSANT POTENTIAL EFFECT IN A MODEL OF EPILEPSY IN RATS WITH COBALT-INDUCED LESIONS
by: I. O. Gaydukov, et al.
Published: (2017-08-01)

Shall we treat patients with benign epileptiform discharges of childhood without epileptic seizures?
by: N. A. Ermolenko, et al.
Published: (2019-05-01)

Possible pathogenetic mechanisms of failure epilepsy treatment with carbamazepine
by: K. V. Krikova, et al.
Published: (2016-08-01)

Study on the antiepyleptic activity of the new amide derivative of valproic acid and 1,3,4-thiadiazole
by: A. S. Malygin
Published: (2020-01-01)

Thymoquinone prevents valproic acid-induced hepatotoxicity via modulation of cytochrome P450, PPARs, and apoptotic pathways
by: Sebile Azirak, et al.
Published: (2025-07-01)

Pharmacological screening of a new valproic acid derivative using the pharmacoencephalography method in rats
by: Yu. I. Sysoev, et al.
Published: (2024-06-01)

Chromatography-tandem MASS spectrometry (HPLC-MS/MS) for the detection of valproic acid and its metabolites in blood plasma
by: A. S. Malygin, et al.
Published: (2018-08-01)

Valproic Acid Enhances the Anticancer Effect of L-Ascorbic Acid by Upregulating Sodium-Dependent Vitamin C Transporter 2 in Colorectal Cancer
by: Kawalin Kantawong, et al.
Published: (2025-07-01)

Hematological, biochemical, coagulation profiles of patients with cerebral palsy and epilepsy on the background of taking valproic acid in the perioperative period
by: V. V. Evreinov
Published: (2024-02-01)

EPILEPSY AT ADULTS: GENDER COMORBIDE DISORDERS, APPLICATION OF VALPROATES
by: P. N. Vlasov
Published: (2016-06-01)

PROBABLE ANTICONVULSIVE MECHANISMS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION AND PREDICTORS OF ITS EFFECTIVITY
by: O. V. Kisten, et al.
Published: (2016-05-01)

Ventral posteromedial nucleus of the thalamus as a neuroanatomical target for the anticephalalgic action of valproic acid and metamizole
by: A. Yu. Sokolov, et al.
Published: (2022-11-01)

MIGRAINE AND EPILEPSY
by: Yu. E. Azimova, et al.
Published: (2016-08-01)

Curcumin exerts protective effects against valproic acid-induced testicular damage through modulating the JAK1/STAT–3/IL–6 signaling pathway in rats
by: Eda Dokumacioglu, et al.
Published: (2025-02-01)

THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CLINICAL PRACTICS
by: Yu. B. Belousov, et al.
Published: (2016-05-01)

CLINICAL AND NEUROLOGICAL MANIFESTATIONS OF DRUG-RESISTANT EPILEPSY AND OPTIMIZATION OF PATIENT TREATMENT
by: Yo. N. Madjidova, et al.
Published: (2019-04-01)

Real-World Efficacy and Tolerability of Switching from Oxcarbazepine to Eslicarbazepine Therapy in Children Aged 6 Years or Older with Focal Epilepsy
by: Sooyoung Lyu, et al.
Published: (2025-07-01)

Study of the anti-inflammatory and immunotropic activity of the secretome from multipotent mesenchymal stromal cells induced by erythropoietin, valproic acid or dexamethasone <i>in vitro</i>
by: P. A. Golubinskaya, et al.
Published: (2022-04-01)

⁠⁠Functional Foods Alleviate Behavioral Alterations and Improve GABAergic System Regulating TLR‐4/NF‐κB Axis in Valproic‐Induced Autism
by: Francesco Molinari, et al.
Published: (2025-06-01)

EEG-predictor’s effectiveness of starting therapy in epilepsy de novo by adult
by: O. V. Grebenyuk, et al.
Published: (2011-04-01)

The use of intravenous valproic acid in patients with epileptic seizures developing during radiation therapy following glial tumor surgery
by: A. S. Shershever, et al.
Published: (2019-10-01)

THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CHILDREN IN CLINICAL PRACTICE
by: M. V. Leonova, et al.
Published: (2017-05-01)

VALIDITY OF STARTING ANTICONVULSANT THERAPY AFTER FIRST CONVULSIVE SEIZURE IN CHILDREN
by: Ye. S. Fetisova, et al.
Published: (2013-10-01)

New Anticonvulsants: Interchangeability Issues and the Use of Generic Anticonvulsants in Clinical Practice
by: V. V. Arkhipov, et al.
Published: (2019-06-01)

RESULTS OF THERAPEUTIC DRUG MONITORING COMBINATION THERAPY OF ANTICONVULSANTS IN CLINICAL PRACTICS
by: M. V. Leonova, et al.
Published: (2016-05-01)

Вenzimidazole derivatives with anticonvulsant activity and their pharmacological targets
by: A. D. Matveev, et al.
Published: (2025-02-01)

OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS
by: T. V. Dokukina, et al.
Published: (2016-05-01)

Valproate-induced thrombocytopenia
by: N. V. Izmozherova, et al.
Published: (2024-04-01)

Pharmacogenetics-Informed Pharmacometabolomics as an Innovative Approach to Assessing the Safety and Risk of Pharmacotherapy with Valproic Acid
by: N. A. Shnayder, et al.
Published: (2023-12-01)

FOTOSENSITIVITY IN CHILDREN AND ADOLESCENTS, ESPECIALLY THE COURSE AND TACTICS
by: I. O. Shchederkina, et al.
Published: (2016-09-01)

Discontinuation of anti-seizure therapy in epilepsy patients
by: O. A. Milovanova, et al.
Published: (2025-05-01)